Morepen Laboratories Gains 5.12%: Key Factors Behind the Weekly Rebound

30 March 2026: Stock Hits 52-Week Low Amid Market Weakness

Morepen Laboratories Ltd’s shares plunged sharply on 30 March 2026, falling 6.45% to close at Rs.33.80 on the BSE. The stock reached an intraday low of Rs.33.44, marking a new 52-week low and continuing a persistent downtrend. This decline was more severe than the Sensex’s 2.29% drop to 32,182.38, signalling significant underperformance.

The fall reflected ongoing challenges in the company’s financial performance, with subdued profit growth and deteriorating liquidity. The stock traded below all key moving averages, indicating sustained bearish momentum. The Pharmaceuticals & Biotechnology sector also faced pressure, though its decline was more moderate at 1.06%, highlighting Morepen Laboratories’ relative weakness.

1 April 2026: Strong Intraday Rally Reverses Downtrend

On 1 April 2026, Morepen Laboratories Ltd staged a robust recovery, surging 10.09% to close at Rs.37.21. The stock opened with a gap up of 4.29% and reached an intraday high of Rs.35.49, representing a 7.16% gain during the session. This rally outpaced the Sensex’s 1.97% gain and the sector’s performance, signalling renewed buying interest.

This rebound followed two consecutive days of decline and was driven by specific factors rather than broad market tailwinds alone, as the stock remained below all major moving averages. The MarketsMOJO Mojo Score remained cautious at 34.0 with a Sell grade, though this marked an upgrade from a previous Strong Sell rating, reflecting a modest improvement in outlook.

2 April 2026: Continued Gains Amid Cautious Market

The positive momentum extended into 2 April 2026, with Morepen Laboratories Ltd closing at Rs.37.98, up 2.07% on the day. The stock’s volume remained robust at 350,544 shares, supporting the upward move. The Sensex was largely flat, gaining just 0.08%, underscoring Morepen Laboratories’ relative strength during the session.

Despite this, the stock continued to trade below all key moving averages, and technical indicators remained mixed. The weekly MACD was mildly bullish, but monthly signals stayed bearish. The cautious market environment and sector pressures suggest that while the stock has staged a short-term recovery, underlying challenges persist.

Daily Price Comparison: Morepen Laboratories Ltd vs Sensex

Key Takeaways from the Week

Positive Signals: The stock’s 12.38% gain from the week’s low to close at Rs.37.98 demonstrates resilience and a potential short-term reversal after hitting a 52-week low. The intraday surge of 7.16% on 1 April was a standout performance, outpacing both the sector and Sensex gains. The upgrade in Mojo Grade from Strong Sell to Sell indicates a slight improvement in outlook.

Cautionary Notes: Despite the rebound, Morepen Laboratories continues to trade below all major moving averages, signalling ongoing technical weakness. The company’s financials remain subdued, with declining profit margins and liquidity concerns. The broader Pharmaceuticals & Biotechnology sector and market indices remain cautious, limiting the scope for sustained rallies. The Mojo Score of 34.0 and Sell rating reflect these ongoing challenges.

Conclusion: A Week of Volatility with Signs of Recovery

Morepen Laboratories Ltd experienced a volatile week marked by a sharp fall to a 52-week low followed by a strong recovery rally. The stock’s 5.12% weekly gain and outperformance relative to the Sensex’s 0.29% decline highlight a notable shift in investor sentiment during the week. However, the company’s fundamental and technical challenges persist, suggesting that while short-term rebounds are possible, caution remains warranted.

Investors should monitor upcoming sessions for confirmation of sustained strength or further volatility, especially given the mixed technical indicators and cautious sector environment.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →